Earlier than the month is over, Pennsylvania residents affected by nervousness issues and Tourette’s syndrome will be capable of entry authorized cannabis.
On Thursday, Pennsylvania’s Division of Well being officers added nervousness dysfunction to the state’s checklist of qualifying situations for medical marijuana, probably opening entry to greater than one million residents.
In keeping with the Philadelphia Inquirer, the DOH Medical Marijuana Advisory Board confirmed nervousness because the state’s 22nd qualifying situation this week after a evaluate by Pennsylvania Well being Secretary Rachel Levine. Along with nervousness dysfunction, Levine and the DOH accredited Tourette’s syndrome as this system’s 23rd qualifying situation.
“I didn’t take this determination calmly,” Levine stated in a press release. “For each situations, medical marijuana shouldn’t be first-line remedy and shouldn’t substitute conventional therapies, however needs to be used along side them, when beneficial by a doctor.”
Pennsylvania’s medical marijuana program started retail dispensary gross sales in early 2018, and has since registered greater than 137,000 sufferers. With the addition of tension and Tourette’s to the checklist of qualifying situations, although, that quantity may shortly develop at an exponential price.
In keeping with statistics from the Nervousness and Despair Affiliation of America dug up by Inquirer reporter Sam Wooden, some 18% of all People endure from nervousness dysfunction, probably translating to greater than 1.7 million Pennsylvanians.
Whereas a lot of states approve particular types of nervousness dysfunction like PTSD as qualifying situations for medical marijuana, solely two different states — New Jersey and Ohio — contemplate common nervousness dysfunction purpose sufficient to entry authorized weed. Coincidentally, Pennsylvania neighbors each of these states.
Along with the almost million-plus Keystone State residents that might quickly qualify for medical cannabis, greater than 200,000 People endure from Tourette’s syndrome, pushing this system’s scope even additional. The brand new program expansions will go into impact subsequent week, on July 21st.
Observe Zach Harris on Twitter